Retatrutide is an investigational triple incretin receptor agonist that simultaneously activates glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Early monitoring supports early intervention and better lifelong brain health
Until recently, tumor surgery, cytotoxic chemotherapy drugs, and radiation therapy remained the cornerstones in cancer treatment
Schedule Your Denture Check-Up at Excel Dental Prioritize Your Oral Health Dont let loose dentures compromise your quality of life
Poster Session II - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.02 - ACUTE MANAGEMENT - Thrombolysis or thrombectomy P716 - ESOC25-2036 IMPACT OF ONSET MODE ON TENECTEPLASE FOR ISCHEMIC STROKE AT 4.5 TO 24 HOURS: A POST-HOC ANALYSIS OF THE TRACE-III TRIAL Zhixin Cao 1 , Jinfeng Yin 2 , Liyuan Wang 1 , Manjun Hao 1 , Shuangzhe Wu 1 , Yunyun Xiong 1,2 , Yongjun Wang 1,2 1 Beijing Tiantan Hospital, Capital Medical University, Beijing, China, 2 China National Clinical Research Center for Neurological Diseases, Beijing, China Background and Aims: Whether the efficacy and safety of tenecteplase is different in patients with wake-up and witnessed onset strokes remains uncertain
N.DearJ
